A detailed history of Kanawha Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Kanawha Capital Management LLC holds 3,340 shares of NVS stock, worth $328,489. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,340
Previous 3,405 1.91%
Holding current value
$328,489
Previous $362,000 6.08%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$106.13 - $120.89 $6,898 - $7,857
-65 Reduced 1.91%
3,340 $384,000
Q1 2024

Apr 29, 2024

BUY
$95.27 - $108.47 $6,192 - $7,050
65 Added 1.95%
3,405 $329,000
Q4 2022

Feb 01, 2023

BUY
$75.55 - $92.52 $5,590 - $6,846
74 Added 2.27%
3,340 $303,000
Q3 2022

Oct 31, 2022

SELL
$74.61 - $87.26 $4,252 - $4,973
-57 Reduced 1.72%
3,266 $248,000
Q2 2022

Jul 27, 2022

BUY
$80.52 - $93.75 $2,979 - $3,468
37 Added 1.13%
3,323 $281,000
Q1 2022

Apr 26, 2022

SELL
$80.11 - $90.62 $4,646 - $5,255
-58 Reduced 1.73%
3,286 $288,000
Q4 2021

Jan 31, 2022

SELL
$79.7 - $88.13 $6,057 - $6,697
-76 Reduced 2.22%
3,344 $292,000
Q3 2021

Oct 28, 2021

BUY
$81.78 - $95.14 $8,995 - $10,465
110 Added 3.32%
3,420 $280,000
Q2 2021

Jul 22, 2021

SELL
$85.24 - $94.15 $3,665 - $4,048
-43 Reduced 1.28%
3,310 $302,000
Q3 2020

Oct 29, 2020

BUY
$82.14 - $91.0 $2,382 - $2,639
29 Added 0.87%
3,353 $292,000
Q4 2019

Jan 31, 2020

BUY
$84.35 - $95.37 $11,809 - $13,351
140 Added 4.4%
3,324 $315,000
Q1 2019

Apr 23, 2019

BUY
$75.32 - $86.15 $3,088 - $3,532
41 Added 1.3%
3,184 $306,000
Q4 2018

Jan 23, 2019

BUY
$73.66 - $82.02 $3,167 - $3,526
43 Added 1.39%
3,143 $270,000
Q3 2017

Oct 26, 2017

BUY
$74.14 - $77.27 $229,834 - $239,537
3,100
3,100 $266,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kanawha Capital Management LLC Portfolio

Follow Kanawha Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kanawha Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kanawha Capital Management LLC with notifications on news.